Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 11 |
GO:0008278 | cohesin complex | 3 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0043226 | organelle | 2 | 11 |
GO:0043227 | membrane-bounded organelle | 3 | 11 |
GO:0043229 | intracellular organelle | 3 | 11 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 11 |
GO:0044815 | DNA packaging complex | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005654 | nucleoplasm | 2 | 1 |
Related structures:
AlphaFold database: A4H4F4
Term | Name | Level | Count |
---|---|---|---|
GO:0006996 | organelle organization | 4 | 12 |
GO:0007062 | sister chromatid cohesion | 3 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016043 | cellular component organization | 3 | 12 |
GO:0022402 | cell cycle process | 2 | 12 |
GO:0051276 | chromosome organization | 5 | 12 |
GO:0071840 | cellular component organization or biogenesis | 2 | 12 |
GO:0000724 | double-strand break repair via homologous recombination | 7 | 1 |
GO:0000725 | recombinational repair | 6 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006259 | DNA metabolic process | 4 | 1 |
GO:0006281 | DNA repair | 5 | 1 |
GO:0006302 | double-strand break repair | 6 | 1 |
GO:0006310 | DNA recombination | 5 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0006950 | response to stress | 2 | 1 |
GO:0006974 | DNA damage response | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0033554 | cellular response to stress | 3 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0050896 | response to stimulus | 1 | 1 |
GO:0051716 | cellular response to stimulus | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1990414 | replication-born double-strand break repair via sister chromatid exchange | 8 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003682 | chromatin binding | 2 | 1 |
GO:0005488 | binding | 1 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 106 | 110 | PF00656 | 0.652 |
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.450 |
CLV_NRD_NRD_1 | 308 | 310 | PF00675 | 0.568 |
CLV_NRD_NRD_1 | 345 | 347 | PF00675 | 0.536 |
CLV_NRD_NRD_1 | 457 | 459 | PF00675 | 0.607 |
CLV_NRD_NRD_1 | 499 | 501 | PF00675 | 0.600 |
CLV_NRD_NRD_1 | 527 | 529 | PF00675 | 0.266 |
CLV_PCSK_KEX2_1 | 161 | 163 | PF00082 | 0.556 |
CLV_PCSK_KEX2_1 | 25 | 27 | PF00082 | 0.264 |
CLV_PCSK_KEX2_1 | 345 | 347 | PF00082 | 0.536 |
CLV_PCSK_KEX2_1 | 459 | 461 | PF00082 | 0.591 |
CLV_PCSK_KEX2_1 | 526 | 528 | PF00082 | 0.265 |
CLV_PCSK_PC1ET2_1 | 25 | 27 | PF00082 | 0.315 |
CLV_PCSK_PC1ET2_1 | 459 | 461 | PF00082 | 0.597 |
CLV_PCSK_SKI1_1 | 25 | 29 | PF00082 | 0.231 |
CLV_PCSK_SKI1_1 | 326 | 330 | PF00082 | 0.580 |
CLV_PCSK_SKI1_1 | 72 | 76 | PF00082 | 0.242 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.431 |
DOC_ANK_TNKS_1 | 461 | 468 | PF00023 | 0.577 |
DOC_CYCLIN_RxL_1 | 69 | 79 | PF00134 | 0.442 |
DOC_MAPK_gen_1 | 205 | 213 | PF00069 | 0.501 |
DOC_MAPK_gen_1 | 25 | 34 | PF00069 | 0.442 |
DOC_MAPK_gen_1 | 309 | 316 | PF00069 | 0.557 |
DOC_MAPK_gen_1 | 487 | 494 | PF00069 | 0.479 |
DOC_MAPK_HePTP_8 | 51 | 63 | PF00069 | 0.431 |
DOC_MAPK_MEF2A_6 | 46 | 53 | PF00069 | 0.456 |
DOC_MAPK_MEF2A_6 | 54 | 63 | PF00069 | 0.408 |
DOC_PP4_FxxP_1 | 287 | 290 | PF00568 | 0.639 |
DOC_USP7_MATH_1 | 217 | 221 | PF00917 | 0.700 |
DOC_USP7_MATH_1 | 334 | 338 | PF00917 | 0.536 |
DOC_USP7_MATH_1 | 417 | 421 | PF00917 | 0.694 |
DOC_USP7_MATH_1 | 475 | 479 | PF00917 | 0.614 |
DOC_USP7_MATH_1 | 539 | 543 | PF00917 | 0.452 |
DOC_USP7_UBL2_3 | 72 | 76 | PF12436 | 0.456 |
LIG_14-3-3_CanoR_1 | 104 | 112 | PF00244 | 0.754 |
LIG_14-3-3_CanoR_1 | 149 | 157 | PF00244 | 0.374 |
LIG_14-3-3_CanoR_1 | 357 | 361 | PF00244 | 0.615 |
LIG_14-3-3_CanoR_1 | 413 | 422 | PF00244 | 0.685 |
LIG_14-3-3_CanoR_1 | 487 | 494 | PF00244 | 0.532 |
LIG_14-3-3_CanoR_1 | 86 | 91 | PF00244 | 0.498 |
LIG_Actin_WH2_2 | 377 | 392 | PF00022 | 0.604 |
LIG_Actin_WH2_2 | 38 | 56 | PF00022 | 0.498 |
LIG_Actin_WH2_2 | 62 | 78 | PF00022 | 0.456 |
LIG_AP2alpha_2 | 285 | 287 | PF02296 | 0.593 |
LIG_BIR_III_2 | 377 | 381 | PF00653 | 0.575 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.589 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.431 |
LIG_FHA_1 | 370 | 376 | PF00498 | 0.587 |
LIG_FHA_1 | 506 | 512 | PF00498 | 0.427 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.442 |
LIG_FHA_2 | 104 | 110 | PF00498 | 0.675 |
LIG_FHA_2 | 166 | 172 | PF00498 | 0.565 |
LIG_FHA_2 | 194 | 200 | PF00498 | 0.446 |
LIG_FHA_2 | 26 | 32 | PF00498 | 0.440 |
LIG_FHA_2 | 292 | 298 | PF00498 | 0.602 |
LIG_FHA_2 | 53 | 59 | PF00498 | 0.433 |
LIG_FHA_2 | 531 | 537 | PF00498 | 0.569 |
LIG_FHA_2 | 558 | 564 | PF00498 | 0.432 |
LIG_LIR_Apic_2 | 284 | 290 | PF02991 | 0.624 |
LIG_LIR_Gen_1 | 147 | 157 | PF02991 | 0.472 |
LIG_LIR_Gen_1 | 199 | 208 | PF02991 | 0.452 |
LIG_LIR_Gen_1 | 533 | 541 | PF02991 | 0.454 |
LIG_LIR_Gen_1 | 82 | 91 | PF02991 | 0.544 |
LIG_LIR_Nem_3 | 147 | 153 | PF02991 | 0.455 |
LIG_LIR_Nem_3 | 177 | 182 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 199 | 203 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 246 | 252 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 533 | 537 | PF02991 | 0.454 |
LIG_LIR_Nem_3 | 82 | 87 | PF02991 | 0.535 |
LIG_MYND_1 | 286 | 290 | PF01753 | 0.654 |
LIG_SH2_NCK_1 | 200 | 204 | PF00017 | 0.470 |
LIG_SH2_SRC | 200 | 203 | PF00017 | 0.473 |
LIG_SH2_STAP1 | 200 | 204 | PF00017 | 0.470 |
LIG_SH2_STAP1 | 393 | 397 | PF00017 | 0.496 |
LIG_SH2_STAP1 | 67 | 71 | PF00017 | 0.466 |
LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.613 |
LIG_SH2_STAT5 | 358 | 361 | PF00017 | 0.669 |
LIG_SH2_STAT5 | 545 | 548 | PF00017 | 0.535 |
LIG_SH2_STAT5 | 6 | 9 | PF00017 | 0.433 |
LIG_SH3_3 | 257 | 263 | PF00018 | 0.628 |
LIG_SH3_3 | 280 | 286 | PF00018 | 0.692 |
LIG_SH3_3 | 381 | 387 | PF00018 | 0.611 |
LIG_SH3_3 | 44 | 50 | PF00018 | 0.431 |
LIG_SUMO_SIM_anti_2 | 533 | 539 | PF11976 | 0.456 |
LIG_SUMO_SIM_par_1 | 33 | 38 | PF11976 | 0.498 |
LIG_SUMO_SIM_par_1 | 49 | 56 | PF11976 | 0.372 |
LIG_SUMO_SIM_par_1 | 536 | 542 | PF11976 | 0.431 |
LIG_TRAF2_1 | 351 | 354 | PF00917 | 0.612 |
LIG_TRAF2_1 | 400 | 403 | PF00917 | 0.490 |
MOD_CK1_1 | 220 | 226 | PF00069 | 0.593 |
MOD_CK1_1 | 228 | 234 | PF00069 | 0.547 |
MOD_CK1_1 | 507 | 513 | PF00069 | 0.608 |
MOD_CK2_1 | 115 | 121 | PF00069 | 0.575 |
MOD_CK2_1 | 165 | 171 | PF00069 | 0.566 |
MOD_CK2_1 | 228 | 234 | PF00069 | 0.714 |
MOD_CK2_1 | 25 | 31 | PF00069 | 0.464 |
MOD_CK2_1 | 291 | 297 | PF00069 | 0.633 |
MOD_CK2_1 | 397 | 403 | PF00069 | 0.581 |
MOD_CK2_1 | 500 | 506 | PF00069 | 0.500 |
MOD_CK2_1 | 52 | 58 | PF00069 | 0.431 |
MOD_CK2_1 | 557 | 563 | PF00069 | 0.430 |
MOD_Cter_Amidation | 159 | 162 | PF01082 | 0.538 |
MOD_Cter_Amidation | 307 | 310 | PF01082 | 0.619 |
MOD_Cter_Amidation | 498 | 501 | PF01082 | 0.580 |
MOD_GlcNHglycan | 150 | 153 | PF01048 | 0.459 |
MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.535 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.519 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.607 |
MOD_GlcNHglycan | 278 | 281 | PF01048 | 0.627 |
MOD_GlcNHglycan | 341 | 344 | PF01048 | 0.589 |
MOD_GlcNHglycan | 381 | 384 | PF01048 | 0.542 |
MOD_GlcNHglycan | 443 | 447 | PF01048 | 0.766 |
MOD_GlcNHglycan | 479 | 482 | PF01048 | 0.442 |
MOD_GlcNHglycan | 546 | 549 | PF01048 | 0.309 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.266 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.568 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.431 |
MOD_GSK3_1 | 215 | 222 | PF00069 | 0.548 |
MOD_GSK3_1 | 225 | 232 | PF00069 | 0.624 |
MOD_GSK3_1 | 318 | 325 | PF00069 | 0.644 |
MOD_GSK3_1 | 356 | 363 | PF00069 | 0.671 |
MOD_GSK3_1 | 413 | 420 | PF00069 | 0.502 |
MOD_GSK3_1 | 477 | 484 | PF00069 | 0.421 |
MOD_GSK3_1 | 500 | 507 | PF00069 | 0.550 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.498 |
MOD_LATS_1 | 498 | 504 | PF00433 | 0.495 |
MOD_N-GLC_2 | 315 | 317 | PF02516 | 0.579 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.431 |
MOD_NEK2_1 | 156 | 161 | PF00069 | 0.575 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.506 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.510 |
MOD_NEK2_1 | 319 | 324 | PF00069 | 0.543 |
MOD_NEK2_1 | 366 | 371 | PF00069 | 0.431 |
MOD_NEK2_1 | 37 | 42 | PF00069 | 0.451 |
MOD_NEK2_1 | 412 | 417 | PF00069 | 0.710 |
MOD_NEK2_1 | 442 | 447 | PF00069 | 0.747 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.480 |
MOD_NEK2_2 | 178 | 183 | PF00069 | 0.426 |
MOD_PIKK_1 | 183 | 189 | PF00454 | 0.522 |
MOD_PIKK_1 | 193 | 199 | PF00454 | 0.489 |
MOD_PIKK_1 | 35 | 41 | PF00454 | 0.535 |
MOD_PIKK_1 | 451 | 457 | PF00454 | 0.502 |
MOD_PK_1 | 104 | 110 | PF00069 | 0.677 |
MOD_PKA_1 | 25 | 31 | PF00069 | 0.431 |
MOD_PKA_1 | 500 | 506 | PF00069 | 0.490 |
MOD_PKA_2 | 103 | 109 | PF00069 | 0.750 |
MOD_PKA_2 | 148 | 154 | PF00069 | 0.374 |
MOD_PKA_2 | 215 | 221 | PF00069 | 0.564 |
MOD_PKA_2 | 236 | 242 | PF00069 | 0.559 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.442 |
MOD_PKA_2 | 356 | 362 | PF00069 | 0.606 |
MOD_PKA_2 | 412 | 418 | PF00069 | 0.572 |
MOD_PKA_2 | 53 | 59 | PF00069 | 0.462 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.474 |
MOD_Plk_1 | 245 | 251 | PF00069 | 0.595 |
MOD_Plk_1 | 490 | 496 | PF00069 | 0.483 |
MOD_Plk_1 | 79 | 85 | PF00069 | 0.448 |
MOD_Plk_2-3 | 121 | 127 | PF00069 | 0.549 |
MOD_Plk_2-3 | 291 | 297 | PF00069 | 0.481 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.431 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.442 |
MOD_Plk_4 | 507 | 513 | PF00069 | 0.592 |
MOD_Plk_4 | 79 | 85 | PF00069 | 0.442 |
TRG_DiLeu_BaEn_2 | 79 | 85 | PF01217 | 0.535 |
TRG_DiLeu_BaLyEn_6 | 564 | 569 | PF01217 | 0.399 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.503 |
TRG_ER_diArg_1 | 161 | 163 | PF00400 | 0.450 |
TRG_ER_diArg_1 | 344 | 346 | PF00400 | 0.564 |
TRG_ER_diArg_1 | 457 | 460 | PF00400 | 0.660 |
TRG_ER_diArg_1 | 525 | 528 | PF00400 | 0.456 |
TRG_NLS_MonoExtC_3 | 308 | 313 | PF00514 | 0.664 |
TRG_NLS_MonoExtC_3 | 457 | 462 | PF00514 | 0.627 |
TRG_NLS_MonoExtC_3 | 499 | 504 | PF00514 | 0.468 |
TRG_NLS_MonoExtN_4 | 307 | 313 | PF00514 | 0.618 |
TRG_NLS_MonoExtN_4 | 457 | 463 | PF00514 | 0.742 |
TRG_NLS_MonoExtN_4 | 500 | 505 | PF00514 | 0.562 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBV6 | Leptomonas seymouri | 66% | 100% |
A0A0S4ISR7 | Bodo saltans | 39% | 100% |
A0A1X0NLU9 | Trypanosomatidae | 45% | 92% |
A0A3S5H5L9 | Leishmania donovani | 86% | 100% |
A0A422NBQ8 | Trypanosoma rangeli | 48% | 99% |
A4HSN1 | Leishmania infantum | 86% | 100% |
C9ZU64 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 98% |
E9AKL6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
Q4QJ93 | Leishmania major | 86% | 100% |
V5D7E1 | Trypanosoma cruzi | 45% | 97% |